CYP3A4 promoter variant in Saudi, Ghanaian and Scottish Caucasian populations-Reference-Cited by-同舟云学术

CYP3A4 promoter variant in Saudi, Ghanaian and Scottish Caucasian populations

Published:2000-11 Issue:8 Volume:10 Page:753-756
ISSN:0960-314X
Container-title:Pharmacogenetics
language:en
Short-container-title:Pharmacogenetics

Author:

Tayeb Mohammed T.,Clark Caroline,Ameyaw Margaret-Mary,Haites Neva E.,Evans David A. Price,Tariq Mohammad,Mobarek Abeer,Ofori-Adjei David,McLeod Howard L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Reference19 articles.

1. RESPONSE: Re: Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4

2. Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4

3. Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions

4. Association of CYP3A4 genotype with treatment-related leukemia

5. Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A descriptive study of the single-nucleotide polymorphisms known to affect the Tacrolimus trough concentration per dose, among a population of kidney failure patients in a tertiary hospital in Ghana;BMC Research Notes;2024-07-29

2. Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective;Pharmacogenomics and Personalized Medicine;2022-06

3. Genetic variants association with cancers in African-based populations: A systematic review;Cancer Epidemiology;2020-08

4. Genotype and Allele Frequency of CYP3A4 -392A>G in Turkish Patients with Major Depressive Disorder;The Turkish Journal of Pharmaceutical Sciences;2018-07-17

5. The role of ethnicity on pregnancy outcomes in women with epilepsy: The need for specific research;Epilepsia;2018-05-04